LORETTA NASTOUPIL to Drug Resistance
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Drug Resistance.
Connection Strength
0.069
-
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Haematologica. 2018 09; 103(9):e416-e418.
Score: 0.035
-
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. Br J Haematol. 2018 09; 182(5):718-723.
Score: 0.034